Статті в журналах з теми "Cxcr1-2"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Cxcr1-2".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Zhang, Jing, Shouguo Huang, Lini Quan, Qiu Meng, Haiyan Wang, Jie Wang, and Jin Chen. "Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis." BioMed Research International 2021 (March 19, 2021): 1–13. http://dx.doi.org/10.1155/2021/8883800.
Doroshenko, Tatyana, Yuri Chaly, Valery Savitskiy, Olga Maslakova, Anna Portyanko, Irina Gorudko, and Nikolai N. Voitenok. "Phagocytosing neutrophils down-regulate the expression of chemokine receptors CXCR1 and CXCR2." Blood 100, no. 7 (October 1, 2002): 2668–71. http://dx.doi.org/10.1182/blood.100.7.2668.
Konrad, F. M., and J. Reutershan. "CXCR2 in Acute Lung Injury." Mediators of Inflammation 2012 (2012): 1–8. http://dx.doi.org/10.1155/2012/740987.
Feniger-Barish, Rotem, Dan Belkin, Alon Zaslaver, Shira Gal, Mally Dori, Maya Ran, and Adit Ben-Baruch. "GCP-2–induced internalization of IL-8 receptors: hierarchical relationships between GCP-2 and other ELR+-CXC chemokines and mechanisms regulating CXCR2 internalization and recycling." Blood 95, no. 5 (March 1, 2000): 1551–59. http://dx.doi.org/10.1182/blood.v95.5.1551.005a36_1551_1559.
Smithson, Alex, Maria Rosa Sarrias, Juanjo Barcelo, Belen Suarez, Juan Pablo Horcajada, Sara Maria Soto, Alex Soriano, et al. "Expression of Interleukin-8 Receptors (CXCR1 and CXCR2) in Premenopausal Women with Recurrent Urinary Tract Infections." Clinical Diagnostic Laboratory Immunology 12, no. 12 (December 2005): 1358–63. http://dx.doi.org/10.1128/cdli.12.12.1358-1363.2005.
Molczyk, Caitlin, and Rakesh K. Singh. "CXCR1: A Cancer Stem Cell Marker and Therapeutic Target in Solid Tumors." Biomedicines 11, no. 2 (February 16, 2023): 576. http://dx.doi.org/10.3390/biomedicines11020576.
Ngo, Hai, Evdoxia Hatjiharissi, Xavier Leleu, Judith Runnels, Anne-Sophie Moreau, Xiaoying Jia, Garrett O’Sullivan, et al. "The CXCR4/SDF-1 Axis Regulates Migration and Adhesion in Waldenstrom Macroglobulinemia." Blood 108, no. 11 (November 1, 2006): 2418. http://dx.doi.org/10.1182/blood.v108.11.2418.2418.
Khandaker, Masud H., Luoling Xu, Rahbar Rahimpour, Gordon Mitchell, Mark E. DeVries, J. Geoffrey Pickering, Sharwan K. Singhal, Ross D. Feldman, and David J. Kelvin. "CXCR1 and CXCR2 Are Rapidly Down-Modulated by Bacterial Endotoxin Through a Unique Agonist-Independent, Tyrosine Kinase-Dependent Mechanism." Journal of Immunology 161, no. 4 (August 15, 1998): 1930–38. http://dx.doi.org/10.4049/jimmunol.161.4.1930.
Vacchini, Alessandro, Anneleen Mortier, Paul Proost, Massimo Locati, Mieke Metzemaekers, and Elena Borroni. "Differential Effects of Posttranslational Modifications of CXCL8/Interleukin-8 on CXCR1 and CXCR2 Internalization and Signaling Properties." International Journal of Molecular Sciences 19, no. 12 (November 27, 2018): 3768. http://dx.doi.org/10.3390/ijms19123768.
Burton, Victoria J., Alan M. Holmes, Loredana I. Ciuclan, Alexander Robinson, Jan S. Roger, Gabor Jarai, Andrew C. Pearce, and David C. Budd. "Attenuation of leukocyte recruitment via CXCR1/2 inhibition stops the progression of PAH in mice with genetic ablation of endothelial BMPR-II." Blood 118, no. 17 (October 27, 2011): 4750–58. http://dx.doi.org/10.1182/blood-2011-05-347393.
Browning, Darren D., Wade C. Diehl, Matthew H. Hsu, Ingrid U. Schraufstatter, and Richard D. Ye. "Autocrine regulation of interleukin-8 production in human monocytes." American Journal of Physiology-Lung Cellular and Molecular Physiology 279, no. 6 (December 1, 2000): L1129—L1136. http://dx.doi.org/10.1152/ajplung.2000.279.6.l1129.
Inngjerdingen, Marit, Bassam Damaj, and Azzam A. Maghazachi. "Expression and regulation of chemokine receptors in human natural killer cells." Blood 97, no. 2 (January 15, 2001): 367–75. http://dx.doi.org/10.1182/blood.v97.2.367.
de Jong, Madelon M. E., Cathelijne Fokkema, Natalie Papazian, Sabrin Tahri, Zoltan Kellermayer, Michael Vermeulen, Mark van Duin, et al. "Inflammasome-Primed Myeloid Cells Maintain a Pro-Tumor Microenvironment in Multiple Myeloma." Blood 138, Supplement 1 (November 5, 2021): 2679. http://dx.doi.org/10.1182/blood-2021-150327.
Troppan, Katharina, Kerstin Wenzl, Peter Neumeister, Christine Beham-Schmid, Martina Przekopowitz, Hildegard T. Greinix, Helmut Schaider, and Alexander JA Deutsch. "The Chemokine Receptor Profile As Distinctive Criterion Between Normal B-Cell Subsets and As Potential Discriminative Marker to Identify the Cell of Origin in Patients with Chronic Lymphocytic Leukemia and Richter Syndrome." Blood 126, no. 23 (December 3, 2015): 3890. http://dx.doi.org/10.1182/blood.v126.23.3890.3890.
Teijeira, Alvaro, Saray Garasa, Itziar Migueliz, Assunta Cirella, and Ignacio Melero. "755 CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (November 2020): A803. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0755.
Bie, Yaqin, Wei Ge, Zhibin Yang, Xianshuo Cheng, Zefeng Zhao, Shengjie Li, Wenchao Wang, et al. "The Crucial Role of CXCL8 and Its Receptors in Colorectal Liver Metastasis." Disease Markers 2019 (November 20, 2019): 1–12. http://dx.doi.org/10.1155/2019/8023460.
Ullman, Nicholas A., Luis I. Ruffolo, Katherine M. Jackson, Alexander Chacon, Mary Georger, Rachel Jewell, Brian A. Belt, Dean Maeda, John Zebala, and David Linehan. "CXCR1/2 blockade to enhance response to immune checkpoint inhibition in an aggressive orthotopic pancreatic adenocarcinoma model." Journal of Clinical Oncology 38, no. 5_suppl (February 10, 2020): 19. http://dx.doi.org/10.1200/jco.2020.38.5_suppl.19.
Molczyk, Caitlin, Elizabeth Thomas, Lubaba Zaman, Paran Goel, and Rakesh K. Singh. "Abstract 894: CXCR1: A novel therapeutic avenue for CSC-like phenotypes in pancreatic ductal adenocarcinoma." Cancer Research 82, no. 12_Supplement (June 15, 2022): 894. http://dx.doi.org/10.1158/1538-7445.am2022-894.
Stadlbauer, V., R. P. Mookerjee, G. A. K. Wright, N. A. Davies, G. Jürgens, S. Hallström, and R. Jalan. "Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis." American Journal of Physiology-Gastrointestinal and Liver Physiology 296, no. 1 (January 2009): G15—G22. http://dx.doi.org/10.1152/ajpgi.90512.2008.
Takata, Hiroshi, Takuya Naruto, and Masafumi Takiguchi. "Functional heterogeneity of human effector CD8+ T cells." Blood 119, no. 6 (February 9, 2012): 1390–98. http://dx.doi.org/10.1182/blood-2011-03-343251.
Мурашко, Д. И., А. Д. Таганович, and Н. Н. Ковганко. "Combined Determination of CXCR1, CXCR2, Hyaluronic Acid and CYFRA 21-1 Receptors in the Blood in the Diagnosis of Non-Small Cell Lung Cancer." Евразийский онкологический журнал, no. 3 (November 1, 2022): 201–16. http://dx.doi.org/10.34883/pi.2022.10.3.014.
Petering, Holger, Otto Götze, Daniela Kimmig, Regina Smolarski, Alexander Kapp, and Jörn Elsner. "The Biologic Role of Interleukin-8: Functional Analysis and Expression of CXCR1 and CXCR2 on Human Eosinophils." Blood 93, no. 2 (January 15, 1999): 694–702. http://dx.doi.org/10.1182/blood.v93.2.694.
Petering, Holger, Otto Götze, Daniela Kimmig, Regina Smolarski, Alexander Kapp, and Jörn Elsner. "The Biologic Role of Interleukin-8: Functional Analysis and Expression of CXCR1 and CXCR2 on Human Eosinophils." Blood 93, no. 2 (January 15, 1999): 694–702. http://dx.doi.org/10.1182/blood.v93.2.694.402k31_694_702.
Le Naour, Augustin, Mélissa Prat, Benoît Thibault, Renaud Mével, Léa Lemaitre, Hélène Leray, Marie-Véronique Joubert, et al. "Tumor cells educate mesenchymal stromal cells to release chemoprotective and immunomodulatory factors." Journal of Molecular Cell Biology 12, no. 3 (September 3, 2019): 202–15. http://dx.doi.org/10.1093/jmcb/mjz090.
Таганович, А. Д., Н. Н. Ковганко, Г. Л. Гуревич, Г. К. Новская, О. А. Будник, О. В. Готько, and В. И. Прохорова. "Verification of Blood Inflammatory Biomarkers Changes in the Diagnosis of Non-Small Cell Lung Cancer." Евразийский онкологический журнал 12, no. 1 (March 25, 2024): 64–72. http://dx.doi.org/10.34883/pi.2024.12.1.024.
Cho, Hee Seong, Young In Choi, Seon Uk Park, Yi Seul Han, Jean Kwon, and Sung Jun Jung. "Prevention of Chemotherapy-Induced Peripheral Neuropathy by Inhibiting C-X-C Motif Chemokine Receptor 2." International Journal of Molecular Sciences 24, no. 3 (January 17, 2023): 1855. http://dx.doi.org/10.3390/ijms24031855.
Xing, Dongqi, J. Michael Wells, Samantha S. Giordano, Wenguang Feng, Amit Gaggar, Jie Yan, Fadi G. Hage, Li Li, Yiu-Fai Chen, and Suzanne Oparil. "Induced pluripotent stem cell-derived endothelial cells attenuate lipopolysaccharide-induced acute lung injury." Journal of Applied Physiology 127, no. 2 (August 1, 2019): 444–56. http://dx.doi.org/10.1152/japplphysiol.00587.2018.
Wolf, Marlene, Maria Belen Delgado, Simon A. Jones, Beatrice Dewald, Ian Clark-Lewis, and Marco Baggiolini. "Granulocyte chemotactic protein 2 acts via both IL- 8 receptors, CXCR1 and CXCR2." European Journal of Immunology 28, no. 1 (January 1998): 164–70. http://dx.doi.org/10.1002/(sici)1521-4141(199801)28:01<164::aid-immu164>3.0.co;2-s.
Liu, Qian, Anping Li, Yijun Tian, Jennifer D. Wu, Yu Liu, Tengfei Li, Yuan Chen, Xinwei Han, and Kongming Wu. "The CXCL8-CXCR1/2 pathways in cancer." Cytokine & Growth Factor Reviews 31 (October 2016): 61–71. http://dx.doi.org/10.1016/j.cytogfr.2016.08.002.
Blaser, Bradley Wayne, Jessica Moore, Brian LI, Owen J. Tamplin, Vera Binder, and Leonard I. Zon. "IL-8 and CXCR1 Remodel the Vascular Niche to Promote Hematopoietic Stem and Progenitor Cell Engraftment." Blood 126, no. 23 (December 3, 2015): 783. http://dx.doi.org/10.1182/blood.v126.23.783.783.
Penco-Campillo, Manon, Clément Molina, Patricia Piris, Nouha Soufi, Manon Carré, Marina Pagnuzzi-Boncompagni, Vincent Picco, et al. "Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas." Cells 11, no. 23 (December 5, 2022): 3933. http://dx.doi.org/10.3390/cells11233933.
Lee, Kyung-Soon, Edelmar Navaluna, Nicole M. Marsh, Eric M. Janezic, and Chris Hague. "Development of a Novel SNAP-Epitope Tag/Near-Infrared Imaging Assay to Quantify G Protein-Coupled Receptor Degradation in Human Cells." SLAS DISCOVERY: Advancing the Science of Drug Discovery 26, no. 4 (January 5, 2021): 570–78. http://dx.doi.org/10.1177/2472555220979793.
Laura, Brandolini, Benedetti Elisabetta, Ruffini Pier Adelchi, Russo Roberto, Cristiano Loredana, Antonosante Andrea, d’Angelo Michele, et al. "CXCR1/2 pathways in paclitaxel-induced neuropathic pain." Oncotarget 8, no. 14 (February 20, 2017): 23188–201. http://dx.doi.org/10.18632/oncotarget.15533.
Pawlick, Rena L., John Wink, Andrew R. Pepper, Antonio Bruni, Nasser Abualhassen, Yasmin Rafiei, Boris Gala-Lopez, Mariusz Bral, and A. M. James Shapiro. "Reparixin, a CXCR1/2 inhibitor in islet allotransplantation." Islets 8, no. 5 (June 21, 2016): 115–24. http://dx.doi.org/10.1080/19382014.2016.1199303.
Lima, Leonardo R. de, Heloisa M. F. Mendes, Frederico M. Soriani, Danielle G. de Souza, Geraldo Eleno S. Alves, Mauro M. Teixeira, and Rafael R. Faleiros. "Histologic and inflammatory lamellar changes in horses with oligofructose-induced laminitis treated with a CXCR1/2 antagonist." Pesquisa Veterinária Brasileira 36, no. 1 (January 2016): 13–18. http://dx.doi.org/10.1590/s0100-736x2016000100002.
Henrot, Pauline, Renaud Prevel, Patrick Berger, and Isabelle Dupin. "Chemokines in COPD: From Implication to Therapeutic Use." International Journal of Molecular Sciences 20, no. 11 (June 6, 2019): 2785. http://dx.doi.org/10.3390/ijms20112785.
Ghasemzadeh, Mehran, Zane S. Kaplan, Imala Alwis, Simone M. Schoenwaelder, Katrina J. Ashworth, Erik Westein, Ehteramolsadat Hosseini, et al. "The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombi." Blood 121, no. 22 (May 30, 2013): 4555–66. http://dx.doi.org/10.1182/blood-2012-09-459636.
Wong, Yin Ping, Noorhafizah Wagiman, Jonathan Wei De Tan, Barizah Syahirah Hanim, Muhammad Syamil Hilman Rashidan, Kai Mun Fong, Naufal Naqib Norhazli, et al. "Loss of CXC-Chemokine Receptor 1 Expression in Chorioamnionitis Is Associated with Adverse Perinatal Outcomes." Diagnostics 12, no. 4 (April 1, 2022): 882. http://dx.doi.org/10.3390/diagnostics12040882.
Mekhloufi, Abdelilah, Andrea Kosta, Helena Stabile, Rosa Molfetta, Alessandra Zingoni, Alessandra Soriani, Marco Cippitelli, et al. "Bone Marrow Stromal Cell-Derived IL-8 Upregulates PVR Expression on Multiple Myeloma Cells via NF-kB Transcription Factor." Cancers 12, no. 2 (February 13, 2020): 440. http://dx.doi.org/10.3390/cancers12020440.
Lippert, Undine, Metin Artuc, Andreas Grützkau, Annelie Möller, Anna Kenderessy-Szabo, Dirk Schadendorf, Johannes Norgauer, et al. "Expression and Functional Activity of the IL-8 Receptor Type CXCR1 and CXCR2 on Human Mast Cells." Journal of Immunology 161, no. 5 (September 1, 1998): 2600–2608. http://dx.doi.org/10.4049/jimmunol.161.5.2600.
Castelli, Vanessa, Laura Brandolini, Michele d’Angelo, Cristina Giorgio, Margherita Alfonsetti, Pasquale Cocchiaro, Francesca Lombardi, Annamaria Cimini, and Marcello Allegretti. "CXCR1/2 Inhibitor Ladarixin Ameliorates the Insulin Resistance of 3T3-L1 Adipocytes by Inhibiting Inflammation and Improving Insulin Signaling." Cells 10, no. 9 (September 6, 2021): 2324. http://dx.doi.org/10.3390/cells10092324.
Citro, Antonio, Elisa Cantarelli, Paola Maffi, Rita Nano, Raffaella Melzi, Alessia Mercalli, Erica Dugnani, et al. "CXCR1/2 inhibition enhances pancreatic islet survival after transplantation." Journal of Clinical Investigation 122, no. 10 (October 1, 2012): 3647–51. http://dx.doi.org/10.1172/jci63089.
Lima, Leonardo R., Heloisa M. Falcão Mendes, Frederico M. Soriani, Geraldo Eleno S. Alves, Danielle G. de Souza, Mauro M. Teixeira, and Rafael R. Faleiros. "Reparixin, an antagonist of CXCR1/2, in experimental laminitis." Journal of Equine Veterinary Science 33, no. 10 (October 2013): 871–72. http://dx.doi.org/10.1016/j.jevs.2013.08.055.
Lu, Min, Lijuan Xia, Mohamed E. Salama, and Ronald Hoffman. "Enriched Populations of Human Megakaryocytic Cells Affect the Behavior of Myelofibrosis CD34+ Cells As Well As Cells Belonging to the MF Supportive Microenvironment." Blood 132, Supplement 1 (November 29, 2018): 3057. http://dx.doi.org/10.1182/blood-2018-99-117062.
Armstrong, Chris, Jonathan Coulter, Pamela Maxwell, Silvia Berlingeri, Joe M. O'Sullivan, Kevin Prise, and David J. Waugh. "Sensitivity of PTEN-deficient prostate carcinoma cells to ionizing radiation through inhibition of treatment-induced CXCL8 signaling." Journal of Clinical Oncology 31, no. 6_suppl (February 20, 2013): 154. http://dx.doi.org/10.1200/jco.2013.31.6_suppl.154.
Kaur, Manpreet, Ramneek, C. S. Mukhopadhyay, and Jaspreet Singh Arora. "PCR-SSCP and Sequencing of CXCR1 (IL8RA) Gene in Indian Water Buffalo." International Journal of Applied Sciences and Biotechnology 4, no. 2 (June 27, 2016): 228–32. http://dx.doi.org/10.3126/ijasbt.v4i2.15128.
Ruffini, P. A., L. Brandolini, R. Russo, A. Cimini, and M. Allegretti. "CXCR1/2 inhibition prevents paclitaxel- and oxaliplatin-induced peripheral neuropathy." European Journal of Cancer 69 (December 2016): S115. http://dx.doi.org/10.1016/s0959-8049(16)32943-4.
Carreira, E. U., V. Carregaro, M. M. Teixeira, A. Moriconi, A. Aramini, W. A. Verri, S. H. Ferreira, F. Q. Cunha, and T. M. Cunha. "Neutrophils recruited by CXCR1/2 signalling mediate post-incisional pain." European Journal of Pain 17, no. 5 (November 7, 2012): 654–63. http://dx.doi.org/10.1002/j.1532-2149.2012.00240.x.
Huang, Yunjia, Jichen Yang, Yong Zhang, Shuhong Kuang, Zongshan Shen, and Wei Qin. "Blocking CXCR1/2 attenuates experimental periodontitis by suppressing neutrophils recruitment." International Immunopharmacology 128 (February 2024): 111465. http://dx.doi.org/10.1016/j.intimp.2023.111465.
Florey, Oliver J., Michael Johns, Olubukola O. Esho, Justin C. Mason та Dorian O. Haskard. "Antiendothelial cell antibodies mediate enhanced leukocyte adhesion to cytokine-activated endothelial cells through a novel mechanism requiring cooperation between FcγRIIa and CXCR1/2". Blood 109, № 9 (23 січня 2007): 3881–89. http://dx.doi.org/10.1182/blood-2006-08-044669.